What is the recommended dosage of promethazine (Phenergan) for adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Promethazine Dosage Recommendations

For adults, promethazine is typically dosed at 12.5-25 mg orally, intravenously, intramuscularly, or rectally every 4-6 hours as needed, with lower doses (6.25-12.5 mg IV) being equally effective for antiemetic purposes while causing less sedation; for children over 2 years of age, the dose is 0.5 mg/kg (12.5-25 mg) every 4-6 hours, with promethazine contraindicated in children under 2 years due to risk of fatal respiratory depression. 1

Adult Dosing by Indication

Nausea and Vomiting

  • Standard dose: 25 mg orally, with repeat doses of 12.5-25 mg every 4-6 hours as necessary 1
  • Lower-dose alternative: 6.25-12.5 mg IV is equally effective for antiemetic purposes and causes significantly less sedation 2, 3
  • Onset of action: Within 5 minutes IV, within 20 minutes orally 2
  • Duration: 4-6 hours after a single dose, though effects may persist up to 12 hours 2

Allergic Conditions

  • Standard regimen: 25 mg at bedtime, or 12.5 mg before meals and at bedtime if necessary 1
  • Alternative: 6.25-12.5 mg three times daily after initiation 1
  • Minor transfusion reactions: 25 mg single dose 1

Motion Sickness

  • Prophylaxis: 25 mg twice daily, with initial dose taken 30-60 minutes before travel and repeated 8-12 hours later 1
  • Subsequent days: 25 mg on arising and before evening meal 1

Sedation

  • Nighttime/presurgical: 25-50 mg at bedtime 1
  • Preoperative: 50 mg the night before surgery, combined with appropriately reduced narcotic/barbiturate doses 1
  • Postoperative: 25-50 mg with reduced analgesic doses 1

Adjunct to Haloperidol for Agitation

  • Combination therapy: 12.5-25 mg IV infused slowly, with total dose of 25-50 mg as adjuvant to haloperidol 2
  • Mechanism: Provides protection against extrapyramidal side effects while adding sedative and antiemetic properties 2

Pediatric Dosing (Children ≥2 Years Only)

Critical Safety Warning

  • Absolute contraindication: Promethazine is contraindicated in children under 2 years of age due to risk of fatal respiratory depression 1, 4
  • Black box warning: Do not use in children under 2 years 1

Weight-Based Dosing

  • General formula: 0.5 mg/kg per dose, adjusted to age, weight, and severity of condition 1
  • Practical range: 12.5-25 mg every 4-6 hours for most indications 1

Specific Indications

  • Nausea/vomiting: 12.5-25 mg every 4-6 hours as needed 1
  • Motion sickness: 12.5-25 mg twice daily 1
  • Allergies: 12.5-25 mg twice daily 1
  • Sedation: 12.5-25 mg at bedtime 1
  • Preoperative: 0.5 mg/kg combined with reduced narcotic/barbiturate doses 1

Route-Specific Considerations

Intravenous Administration

  • Infusion rate: Must be administered slowly at ≤25 mg/min to minimize hypotension risk 2
  • Tissue damage risks: Thrombophlebitis, tissue necrosis, and gangrene can occur with IV administration 2
  • Preferred for acute settings: When oral medication cannot be tolerated 1

Intramuscular Administration

  • Preferred site in adults: Deltoid muscle 5
  • Preferred site in infants/young children: Anterolateral thigh (vastus lateralis muscle) due to low risk of vascular or nerve damage 5

Oral Administration

  • Equivalent to parenteral: No advantage of IV/IM over oral route if GI absorption is intact 6
  • Bioavailability consideration: Enteric promethazine has 25% bioavailability, yet current dosing is identical across routes 3

Critical Safety Considerations

Respiratory Depression

  • High-risk populations: Children, elderly, patients receiving concurrent opioids 2, 7
  • Cumulative dosing risk: Risk increases with repeated dosing 2
  • Monitoring: Respiratory depression can occur within 30 minutes even at recommended doses 7
  • Case reports: Respiratory arrest has occurred in children receiving 0.07 ml/kg of meperidine-promethazine-chlorpromazine combination 7

Sedation

  • Dose-dependent: Significant sedation occurs, particularly problematic with repeated dosing or opioid combination 2
  • Lower-dose benefit: 6.25 mg IV causes significantly less sedation than 12.5 mg while maintaining equal efficacy 8

Extrapyramidal Effects

  • Risk: Neuroleptic malignant syndrome and other extrapyramidal effects can occur 2
  • Implication: Makes promethazine inappropriate for chronic use 2

Special Populations

  • Elderly: Starting dose of 6.25 mg IV is as effective as higher doses with fewer adverse drug reactions 8
  • Combination with opioids: Requires dose reduction of standard sedation agents 2

Practical Dosing Algorithm

  1. Verify age: Confirm patient is ≥2 years old (absolute contraindication if younger) 1
  2. Select route: Oral preferred if tolerated; IV for acute settings with slow infusion 1, 2
  3. Choose dose:
    • Adults: Start with 12.5 mg IV or 25 mg PO for most indications 2, 1
    • Elderly: Start with 6.25 mg IV 8
    • Children ≥2 years: 0.5 mg/kg (12.5-25 mg range) 1
  4. Adjust to minimum effective dose: Titrate to smallest amount adequate to relieve symptoms 1
  5. Repeat dosing: Every 4-6 hours as necessary, monitoring for respiratory depression 1, 2

References

Guideline

Promethazine Prescription Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Recommended Site for Intramuscular Promethazine Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.